Inhibitors of glycogen synthase kinase 3
New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combinat...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Nuss, John M Harrison, Stephen D Ring, David B Boyce, Rustum S Johnson, Kirk Pfister, Keith B Ramurthy, Savithri Seely, Lynn Wagman, Allan S Desai, Manoj C Levine, Barry H |
| description | New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07045519</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07045519</sourcerecordid><originalsourceid>FETCH-uspatents_grants_070455193</originalsourceid><addsrcrecordid>eNrjZNDwzMvITMosyS8qVshPU0jPqUzOT0_NUyiuzCvJSCxOVcjOzANRxjwMrGmJOcWpvFCam0HBzTXE2UO3tLggsSQ1r6Q4Pr0oEUQZmBuYmJoaWhoToQQAn2spAA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibitors of glycogen synthase kinase 3</title><source>USPTO Issued Patents</source><creator>Nuss, John M ; Harrison, Stephen D ; Ring, David B ; Boyce, Rustum S ; Johnson, Kirk ; Pfister, Keith B ; Ramurthy, Savithri ; Seely, Lynn ; Wagman, Allan S ; Desai, Manoj C ; Levine, Barry H</creator><creatorcontrib>Nuss, John M ; Harrison, Stephen D ; Ring, David B ; Boyce, Rustum S ; Johnson, Kirk ; Pfister, Keith B ; Ramurthy, Savithri ; Seely, Lynn ; Wagman, Allan S ; Desai, Manoj C ; Levine, Barry H ; Chiron Corporation</creatorcontrib><description>New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.</description><language>eng</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7045519$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7045519$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Nuss, John M</creatorcontrib><creatorcontrib>Harrison, Stephen D</creatorcontrib><creatorcontrib>Ring, David B</creatorcontrib><creatorcontrib>Boyce, Rustum S</creatorcontrib><creatorcontrib>Johnson, Kirk</creatorcontrib><creatorcontrib>Pfister, Keith B</creatorcontrib><creatorcontrib>Ramurthy, Savithri</creatorcontrib><creatorcontrib>Seely, Lynn</creatorcontrib><creatorcontrib>Wagman, Allan S</creatorcontrib><creatorcontrib>Desai, Manoj C</creatorcontrib><creatorcontrib>Levine, Barry H</creatorcontrib><creatorcontrib>Chiron Corporation</creatorcontrib><title>Inhibitors of glycogen synthase kinase 3</title><description>New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZNDwzMvITMosyS8qVshPU0jPqUzOT0_NUyiuzCvJSCxOVcjOzANRxjwMrGmJOcWpvFCam0HBzTXE2UO3tLggsSQ1r6Q4Pr0oEUQZmBuYmJoaWhoToQQAn2spAA</recordid><startdate>20060516</startdate><enddate>20060516</enddate><creator>Nuss, John M</creator><creator>Harrison, Stephen D</creator><creator>Ring, David B</creator><creator>Boyce, Rustum S</creator><creator>Johnson, Kirk</creator><creator>Pfister, Keith B</creator><creator>Ramurthy, Savithri</creator><creator>Seely, Lynn</creator><creator>Wagman, Allan S</creator><creator>Desai, Manoj C</creator><creator>Levine, Barry H</creator><scope>EFH</scope></search><sort><creationdate>20060516</creationdate><title>Inhibitors of glycogen synthase kinase 3</title><author>Nuss, John M ; Harrison, Stephen D ; Ring, David B ; Boyce, Rustum S ; Johnson, Kirk ; Pfister, Keith B ; Ramurthy, Savithri ; Seely, Lynn ; Wagman, Allan S ; Desai, Manoj C ; Levine, Barry H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_070455193</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Nuss, John M</creatorcontrib><creatorcontrib>Harrison, Stephen D</creatorcontrib><creatorcontrib>Ring, David B</creatorcontrib><creatorcontrib>Boyce, Rustum S</creatorcontrib><creatorcontrib>Johnson, Kirk</creatorcontrib><creatorcontrib>Pfister, Keith B</creatorcontrib><creatorcontrib>Ramurthy, Savithri</creatorcontrib><creatorcontrib>Seely, Lynn</creatorcontrib><creatorcontrib>Wagman, Allan S</creatorcontrib><creatorcontrib>Desai, Manoj C</creatorcontrib><creatorcontrib>Levine, Barry H</creatorcontrib><creatorcontrib>Chiron Corporation</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Nuss, John M</au><au>Harrison, Stephen D</au><au>Ring, David B</au><au>Boyce, Rustum S</au><au>Johnson, Kirk</au><au>Pfister, Keith B</au><au>Ramurthy, Savithri</au><au>Seely, Lynn</au><au>Wagman, Allan S</au><au>Desai, Manoj C</au><au>Levine, Barry H</au><aucorp>Chiron Corporation</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibitors of glycogen synthase kinase 3</title><date>2006-05-16</date><risdate>2006</risdate><abstract>New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07045519 |
| source | USPTO Issued Patents |
| title | Inhibitors of glycogen synthase kinase 3 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A57%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Nuss,%20John%20M&rft.aucorp=Chiron%20Corporation&rft.date=2006-05-16&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07045519%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |